Skip to main navigation
Skip to search
Skip to main content
University of Hertfordshire (Research Profiles) Home
Search content at University of Hertfordshire (Research Profiles)
Home
Profiles
Research output
Projects
Research units
‘Special M’ related fatalities in the UK.
Stephania Chiappini
, Hugh Claridge
,
John Corkery
, Christine Goodair
, Barbara Loi
,
Fabrizio Schifano
Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
Department of Clinical, Pharmaceutical and Biological Science
Centre for Health Services and Clinical Research
Research output
:
Contribution to journal
›
Meeting abstract
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of '‘Special M’ related fatalities in the UK.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Methoxetamine
100%
Fatality
100%
Drug-related Deaths
20%
Coroner
20%
Health Effects
20%
Hallucinations
10%
Poisoning
10%
Competitive Antagonist
10%
Adverse Effects
10%
Euphoria
10%
Dissociative Anesthetics
10%
Guernsey
10%
Dissociation
10%
Novel Psychoactive Substances
10%
Regional Authorities
10%
Posters
10%
Empathy
10%
Physical Body
10%
Research Chemicals
10%
Ketamine
10%
Behavioral Effects
10%
Dopamine Reuptake Inhibitor
10%
Jersey
10%
Substance Abuse
10%
National Program
10%
World Wide Web
10%
Cognitive Impairment
10%
N-methyl-D-aspartate Receptor (NMDAR)
10%
Early Intervention
10%
Healthcare Professionals
10%
Cardiovascular Manifestations
10%
Isle of Man
10%
Toxicity Potential
10%
Intervention Measures
10%
Cerebellar Signs
10%
Medicine and Dentistry
Fatality
100%
Methoxetamine
100%
Medical Examiner
20%
Cognitive Defect
10%
Empathy
10%
Side Effect
10%
Competitive Antagonist
10%
Hallucination
10%
Ketamine
10%
Euphoria
10%
Cardiovascular Symptom
10%
N Methyl-D-Aspartate Receptor
10%
Intoxication
10%
Early Intervention
10%
Substance Abuse
10%
Health Care
10%
Dopamine Reuptake Inhibitor
10%
Anesthetic Agent
10%
Behavioral Effect
10%
Pharmacology, Toxicology and Pharmaceutical Science
Fatality
100%
Methoxetamine
100%
Ketamine
10%
Competitive Antagonist
10%
Dopamine Reuptake Inhibitor
10%
Side Effect
10%
Cardiovascular Symptom
10%
Anesthetic Agent
10%
Cognitive Defect
10%
Toxic Injury
10%
Receptor
10%
Aspartic Acid
10%
Hallucination
10%
Behavioral Effect
10%